Industry News
Medical Device Industry News
Labcorp On the Verge of Acquiring Invitae’s Assets
The Burlington, NC-based company has been selected as the winning bidder to acquire Invitae’s assets for $239 million.
Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation
“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a
Asimov Achieves 10x Improvement In Lentiviral Production, Launches New Stable Cell Line Development Service
The LV Edge Producer System completely eliminates GMP plasmid cost and greatly reduces process complexity and variability by stably integrating all the genes for lentiviral production into the host cell notes Asimov.
MGS Heralds New Milestone in Best-in-Class Toolmaking for Medtech OEMs
Upgrades to a recently acquired moldmaking shop in Denmark include 5-axis laser texturing and high-speed milling as well as automated handling systems.
Elekta Disposable Biopsy Needle Recall Identified as Class I
The company is recalling the needles from one batch as it may contain microscopic stainless-steel debris on the inside of the needle.
Identifying the Privacy & Ethical Pitfalls in Connected Medical Devices
Bethany Corbin details the importance of understanding these issues, citing femtech examples like reproductive health privacy post-Dobbs v. Jackson Women’s Health Organization and potential alienation of intended users.
Edwards Isn’t Sweating the SMART Results
The company addressed results from a clinical trial that pitted Medtronic’s Evolut platform against the Sapien valve.
Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya’s Scientific Advisory Board,
How Can Wearable Health Technology Boost Driver Safety and Well-being?
Wearable health technology can measure a host of vital information, including heart rate, heart rate variability, and blood pressure. The information it provides can be a key aid for drivers wishing to stay safe.
A New Vision for Pixium’s Retinal Implants
Science Corporation, a brain-computer interface specialist, is acquiring the IP and related assets for Pixium’s Prima Retinal Implants. The acquisition comes a few months after Pixium announced it was looking at strategic alternatives.
VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey
As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.
Boston Scientific’s Farapulse Is a Showstopper
Electrophysiologists are giving the new pulsed field ablation system a warm welcome.
Proven Insights for Efficient Medical Device Design & Development
A look at the tools and strategies you need for strong product development.
CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine
“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists
New Medical Devices & Partnerships Could Break Barriers & Lead to Better Heart Failure Care
New technologies like wireless patch electrocardiograms and cellular-connected scales aim to change remote heart failure care, potentially leading to earlier detection and more efficient management.
Services
Find contract manufacturers, consultants, and other outsourcing partners.
Equipment
Browse new equipment used in molding, packaging, surface treatment, and other applications.
Products & Supplies
See the latest components, materials, tubing, and more.
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan
Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US
Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel,